Regenerative Medical Technology Group Inc.

OTCPK:MSSV Stock Report

Market Cap: US$326.0k

Regenerative Medical Technology Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Dave Christensen

Chief executive officer

US$90.0k

Total compensation

CEO salary percentage100.0%
CEO tenure4.9yrs
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Dave Christensen's remuneration changed compared to Regenerative Medical Technology Group's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$10m

Mar 31 2024n/an/a

-US$10m

Dec 31 2023US$90kUS$90k

-US$10m

Sep 30 2023n/an/a

-US$11m

Jun 30 2023n/an/a

-US$6m

Mar 31 2023n/an/a

-US$6m

Dec 31 2022US$90kUS$90k

-US$6m

Sep 30 2022n/an/a

-US$6m

Jun 30 2022n/an/a

-US$15m

Mar 31 2022n/an/a

-US$14m

Dec 31 2021US$563kUS$60k

-US$13m

Sep 30 2021n/an/a

-US$6m

Jun 30 2021n/an/a

-US$3m

Mar 31 2021n/an/a

-US$6m

Dec 31 2020US$222kUS$55k

-US$6m

Sep 30 2020n/an/a

-US$13m

Jun 30 2020n/an/a

-US$7m

Mar 31 2020n/an/a

-US$672k

Dec 31 2019US$53kUS$5k

-US$3m

Compensation vs Market: Dave's total compensation ($USD90.00K) is below average for companies of similar size in the US market ($USD667.78K).

Compensation vs Earnings: Dave's compensation has been consistent with company performance over the past year.


CEO

Dave Christensen (58 yo)

4.9yrs

Tenure

US$90,000

Compensation

Mr. David E. Christensen, also known as Dave, serves as Chief Executive Officer, Chief Financial Officer and Secretary at Regenerative Medical Technology Group Inc. (formerly known as Meso Numismatics, Inc...